Generating vasculogenic cell populations
US12098390B2 · kind B2 · utility
0Cited by
7References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 16, 2021 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | Aug 16, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/45
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to methods and compositions useful for therapeutic vascular tissue engineering. In particular, the present invention provides methods for generating substantially pure populations of vasculogenic cells from human mesenchymal progenitors, and methods and compositions for clinical applications in the field of regenerative medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.